The award will fund optimization of the Hemopurifier exosome isolator, with an eye towards developing applications in cancer research and clinical care.
The blood-based test is designed to detect changes in levels of microRNAs that are enriched in specific brain regions affected by Alzheimer's disease.
The team will use a combination of genomics, pathology, and computer modeling to identify potential new therapeutic targets of the disease.
The project is funded with £50 million from the UK government, £50 million from the Wellcome Trust, and £100 million from four pharmaceutical firms.
The funding will support the use of a new in situ RNA sequencing technology, STARmap, to build functional maps of the developing brain and brain tumors.
The funding is being provided by the Flemish government's Agency for Innovation and Entrepreneurship to support the three-year development project.
Funded projects will look at the combination of imaging and liquid biopsies for monitoring cancer patient responses and the emergence of treatment resistance.
The center, launched by the National University of Ireland Galway, plans to train 115 doctoral students in genomics data science over the next seven years.
Project partners will expand on infrastructure developed by DNAstack for accessing genomic data and explore patient consent models that support nationwide sharing.
The researchers will evaluate recent developments in human genome editing as well as responses from the public and scientific communities.
The projects are focused on the impact of microbe communities on soil nutrient cycling, and the relationship between gene function and beneficial plant traits.
The platform is designed to isolate exosomes from blood, then release their extracellular RNA cargo for analysis as biomarkers for diseases including cancer.
The program, launched last year, is designed to help early-career investigators who have primarily worked within groups pursuing independent research.
Fluidigm will develop a microfluidic device for single-cell measurement of epigenetic changes under a broader $27.8 million DARPA-funded project.
The All of Us program aims to enroll 1 million Americans willing to donate biological samples and share a variety of genetic and health data.
The Long Life Family Study has enrolled 4,953 participants in 539 pedigrees in the US and Denmark that are enriched for exceptional longevity.
The five-year project aims to analyze environmental DNA in three Maine watersheds to improve the management of the state's coastal ecosystems.
The team will create a group called the Extracellular RNA Communication Consortium Stage 2 to develop new EV-based technology and treat diseases.
The drug developer said that the biomarker panel will form the basis of a planned point-of-care test for acute respiratory distress syndrome.
The company will provide counseling in multiple languages and connect people to local healthcare resources so they can use the genetic information they've learned in their own care.
Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.
An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.
Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.
In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.